Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

502 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial.
Tobe SW, Pylypchuk G, Wentworth J, Kiss A, Szalai JP, Perkins N, Hartman S, Ironstand L, Hoppe J. Tobe SW, et al. Among authors: hoppe j. CMAJ. 2006 Apr 25;174(9):1267-71. doi: 10.1503/cmaj.050030. Epub 2006 Apr 4. CMAJ. 2006. PMID: 16595786 Free PMC article. Clinical Trial.
Diabetes risk evaluation and microalbuminuria (DREAM) studies: ten years of participatory research with a First Nation's home and community model for type 2 diabetes care in Northern Saskatchewan.
Pylypchuk G, Vincent L, Wentworth J, Kiss A, Perkins N, Hartman S, Ironstand L, Hoppe J, Tobe SW. Pylypchuk G, et al. Among authors: hoppe j. Int J Circumpolar Health. 2008 Jun;67(2-3):190-202. doi: 10.3402/ijch.v67i2-3.18264. Int J Circumpolar Health. 2008. PMID: 18767339 Free article. Review.
Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial.
Hoppe JE, Kasi AS, Pittman JE, Jensen R, Thia LP, Robinson P, Tirakitsoontorn P, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Salinas DB, Zhu J, Chen YC, Rodriguez-Romero V, Sosnay PR, Davies G. Hoppe JE, et al. Lancet Respir Med. 2024 Dec 20:S2213-2600(24)00407-7. doi: 10.1016/S2213-2600(24)00407-7. Online ahead of print. Lancet Respir Med. 2024. PMID: 39756425 Free article.
Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease.
Benkhoff M, Barcik M, Mourikis P, Dahlmanns J, Kahmann P, Wollnitzke P, Hering M, Huckenbeck T, Hoppe J, Semleit N, Deister-Jonas J, Zako S, Seel J, Coman C, Barth M, Cramer M, Helten C, Wildeis L, Hu H, Al-Kassis G, Metzen D, Hesse J, Weber J, Dannenberg L, Akhyari P, Lichtenberg A, Quast C, Gerdes N, Zeus T, Borst O, Kelm M, Petzold T, Ahrends R, Levkau B, Polzin A. Benkhoff M, et al. Among authors: hoppe j. Circulation. 2024 Oct 21. doi: 10.1161/CIRCULATIONAHA.123.067270. Online ahead of print. Circulation. 2024. PMID: 39429140
The Toxicology Investigators Consortium 2023 Annual Report.
Hughes A, Amaducci A, Campleman SL, Li S, Costantini M, Spyres MB, Spungen H, Kent J, Falise A, Culbreth R, Wax PM, Brent J, Aldy K; Toxicology Investigators Consortium Study Group. Hughes A, et al. J Med Toxicol. 2024 Oct;20(4):350-380. doi: 10.1007/s13181-024-01033-w. Epub 2024 Sep 10. J Med Toxicol. 2024. PMID: 39256327
502 results